In this Issue:
Targeting BCL2 with venetoclax in relapsed CLL
Mortality, second malignancies and hospitalisation in young Hodgkin’s lymphoma survivors
Rituximab + fludarabine/ cyclophosphamide improves OS in newly diagnosed MCL
Defining CR after allogeneic HSCT for AML
Transplant with peripheral blood vs. bone marrow after RIC for acute leukaemia
Caplacizumab for acquired TTP
VTE risk in breast cancer
Fertility/sexual health problems following allogeneic HSCT
Rivaroxaban versus standard anticoagulation for symptomatic DVT
Please login below to download this issue (PDF)